Balance Sheet Components - Schedule of Other Accrued Expenses and Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Accrued research and development expenses - Contract Research Organizations	$ 6,423	$ 5,669
Accrued research and development expenses - Contract Manufacturing Organizations	3,726	5,487
Other accrued expenses	1,757	2,903
Total other accrued expenses and current liabilities	$ 11,906	$ 14,059

Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Name:	us-gaap_OtherAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant